Percutaneous Treatment of Hydatid Liver Cyst

Authors:
  • ASAntonella Sarno
    Antonella Sarno
  • GSGiorgio de Stefano
    Giorgio de Stefano
  • NFNunzia Farella
    Nunzia Farella
  • PMPaolo Matteucci
    Paolo Matteucci
  • USUmberto Scognamiglio
    Umberto Scognamiglio
  • VGValentina Giorgio
    Valentina Giorgio

Abstract
Percutaneous treatment of Hydatid Liver Cyst (HLC) with scolicidal agent under ultrasound guidance is now worldwide used after the advent of Percutaneous-Aspiration-Injection and Re-Aspiration (PAIR) and its modifications. Although HLC represent a benign disease, treatment has to be considered mandatory in symptomatic cysts and recommended in viable cysts because of the risk of severe complications. In this article, clinical indications, PAIR technique with results and complications are discussed. Finally, clinical flow-chart of active and inactive HLCs is reported. The present article is a review of some patents in the Hydatid liver cyst.